MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD)

    E. Brown, D. Alonso, L. Chahine, C. Coffey, R. Dobkin, M. Korell, A. Lorenzo, C. Marras, W. Poewe, T. Sherer, A. Siderowf, T. Simuni, E. Tolosa, J. Valverde Twiggs, D. Weintraub, S. Chowdhury, K. Marek, C. Tanner (San Francisco, USA)

    Objective: To establish a large, longitudinal online cohort linked with a selected, intensively assessed cohort of people with and without PD to characterize development and…
  • 2022 International Congress

    Impact of Nonmotor Symptoms on The Quality of Life of Parkinson’s Disease Patients

    R. Nindela, O. Tambun, S. Marisdina, E. Bahar (Palembang, Indonesia)

    Objective: This study examined the effect of nonmotor symptoms on the quality of life (QoL) of Parkinson's disease (PD) patients. Background: Parkinson's disease has a…
  • 2022 International Congress

    Relative bioavailability of levodopa administered as a subcutaneous infusion with ND0612 versus oral immediate-release levodopa/carbidopa tablets

    L. Adar, N. Vostokova (Rehovot, Israel)

    Objective: To determine the relative bioavailability of levodopa when administered as a subcutaneous (SC) levodopa/carbidopa (LD/CD) infusion with ND0612 versus levodopa derived from oral immediate-release…
  • 2022 International Congress

    Genetic contribution to domain specific cognitive decline

    V. Livneh, N. Omer, N. Giladi, T. Gurevich, A. Bar-Shira, M. Gana-Weisz, O. Goldstein, J. Shirvan, J. Cedarbaum, A. Orr-Urtreger, R. Alcalay, A. Mirelman, A. Thaler (Tel Aviv, Israel)

    Objective: To assess differences in cognitive domains  between patients with Parkinson’s disease with the LRRK2 and GBA risk mutations Background: Most patients with PD show…
  • 2022 International Congress

    Biochemical markers of glucocerebrosidase (GCase) deficiency in primary macrophages derived from GBA1 mutation carriers with and without Parkinson’s disease

    S. Pchelina, A. Kopytova, M. Nikolaev, A. Emelyanov, G. Baydakova, T. Usenko, A. Izymchenko, D. Bogdanova, K. Senkevich, I. Miliukhina, Y. Zakharova (Gatchina, Russian Federation)

    Objective: The aim of the present study was to assess biochemical markers in primary macrophages that could distinguish patient with Parkinson’s disease linked to mutations…
  • 2022 International Congress

    Binaural acoustic stimulation reduces tremor severity in patients suffering from Parkinson’s disease

    A. Calvano, L. Timmermann, C. Oehrn, I. Weber (Marburg, Germany)

    Objective: To assess the effects of BBS on motor symptoms in PD. Background: Acoustic stimulation (AS) can improve motor symptoms in Parkinson’s disease (PD) and…
  • 2022 International Congress

    Validation of the PD Home Diary for Assessment of Motor Fluctuations in Advanced Parkinson’s Disease

    M. Löhle, A. Bremer, F. Gandor, J. Timpka, P. Odin, G. Ebersbach, A. Storch (Rostock, Germany)

    Objective: To determine the validity of the Parkinson’s disease (PD) home diary for quantification of motor states in patients with advanced PD and motor fluctuations.…
  • 2022 International Congress

    A randomized clinical trial (RCT) to evaluate the effects of safinamide on apathetic non-demented Parkinson’s disease patients

    J. Kulisevsky, S. Martinez-Horta, A. Campolongo, B. Pascual-Sedano, J. Marin-Lahoz, H. Bejr-Kasem, A. Horta-Barba, A. Puig-Davi, J. Pagonabarraga, I. Aracil-Bolaños, J. Rodriguez-Antiguedad (Barcelona, Spain)

    Objective: To evaluate the safety and effects of add-on safinamide on apathy in patients with Parkinson’s disease (PD). Background: Apathy is highly prevalent and disabling…
  • 2022 International Congress

    Network Fingerprint of Stimulation-Induced Speech Impairment in Parkinson’s Disease

    H. Jergas, JN. Petry-Schmelzer, JG. Hannemann, T. Thies, JC. Baldermann, JN. Strelow, HS. Dafsari, D. Muecke, V. Visser-Vandewalle, TA. Dembek, MT. Barbe (Cologne, Germany)

    Objective: To explore structural network correlates of stimulation-induced dysarthria (SID) in patients with Parkinson’s Disease (PD) chronically treated with deep brain stimulation (DBS) of the…
  • 2022 International Congress

    Remote keyboard tapping: potential signatures of early motor dysfunction in isolated REM sleep behaviour disorder

    C. Simonet, L. Perez-Carbonell, H. Chohan, N. Akram, H. Li, A. Gill, J. Bestwick, A. Lees, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To compare keyboard tapping performance in people with iRBD with controls. Background: The Distal Finger Tapping (DFT)1 test and BRadykineisa Akinesia Incoordination test (BRAIN)2…
  • « Previous Page
  • 1
  • …
  • 253
  • 254
  • 255
  • 256
  • 257
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley